Search

Search Constraints

You searched for: Author/Creator Heng, A.‐E.

Search Results

1. Kidney Transplant Recipients Carrying the CYP3A4*22 Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations. Issue 3 (14th January 2015)

2. Long‐Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. Issue 9 (8th April 2016)

3. Predictive Modeling of Tacrolimus Dose Requirement Based on High‐Throughput Genetic Screening. Issue 4 (7th October 2016)

4. Pre‐transplant end‐stage renal disease‐related immune risk profile in kidney transplant recipients predicts post‐transplant infections. Issue 3 (21st May 2016)

5. Reduction of Extended‐Release Tacrolimus Dose in Low‐Immunological‐Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor‐Specific Antibodies: A Randomized Study. Issue 5 (3rd January 2017)